Security key
16385C104
Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB)
CUSIP: 16385C104
Q2 2021 13F Holders as of 30 Jun 2021
- Security type / class
- Equity / Ordinary Shares / American Depositary Shares
- Total 13F shares
- 3,085,723
- Total 13F value
- $58,690,000
- Share change
- +208,731
- SEC-reported price per share
- $19.02
- Number of holders
- 11
- Value change
- +$1,761,108
- Number of buys
- 7
- Number of sells
- 8
- Shares outstanding
- 412,914,375
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2021
Institutions
11
Top holders
10
CMMB full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Chemomab Therapeutics Ltd. SEC filings
Chemomab Therapeutics Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 16385C104
Recent filing periods:
Ownership snapshot
Top reported holders of CMMB - Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Novo Holdings A/S
Disclosed value leader
Novo Holdings A/S
Comparable rows
15/15
Latest evidence
31 Mar 2021
13F
Lead comparable stake: 33%
Showing 1-6 of 15 holder rows.
Quick read
Novo Holdings A/S leads the comparable SEC ownership view at 33%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Novo Holdings A/S's linked filing trail.
Comparable ownership
Top 5
Novo Holdings A/S
33%
Cormorant Asset Management, LP
29%
Soleus Capital Management, L.P.
20%
Janus Henderson Group Ltd.
18%
BlackRock Finance, Inc.
7.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Novo Holdings A/S |
13F
Company
|
33%
|
$15,162,000
2,497,791 shares
|
— | 31 Mar 2021 |
| Cormorant Asset Management, LP |
13F
Company
|
29%
|
$13,066,000
2,150,732 shares
|
— | 31 Mar 2021 |
| Soleus Capital Management, L.P. |
13F
Company
|
20%
|
$9,189,000
1,512,648 shares
|
— | 31 Mar 2021 |
| Janus Henderson Group Ltd. |
13F
Company
|
18%
|
$7,827,000
1,321,929 shares
|
— | 31 Mar 2021 |
| BlackRock Finance, Inc. |
13F
Company
|
7.2%
|
$3,274,000
538,896 shares
|
— | 31 Mar 2021 |
| MAVERICK CAPITAL LTD |
13F
Company
|
6.4%
|
$2,900,000
482,672 shares
|
— | 31 Mar 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
11
Shares
3,085,723
Rows available
11
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
10
Q2 2021 holders
11
Holder diff
1
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 value | Q2 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend